XML 55 R39.htm IDEA: XBRL DOCUMENT v3.24.1
Stockholders’ Equity (Details) - USD ($)
 12 Months Ended
Oct. 31, 2023
Oct. 31, 2022
Sep. 29, 2022
Sep. 28, 2022
Sep. 26, 2022
Aug. 29, 2022
Mar. 31, 2022
Jan. 27, 2022
Jan. 26, 2022
Dec. 29, 2021
Dec. 31, 2023
Dec. 31, 2022
Jan. 09, 2024
Dec. 04, 2023
Feb. 09, 2021
Jan. 18, 2021
Stockholders’ Equity [Line Items]                                
Common stock, shares authorized                     100,000,000 100,000,000        
Shares authorized                     105,000,000          
Designated shares                     4,280          
Preferred stock, par value (in Dollars per share)                     $ 0.0001 $ 0.0001        
Series C convertible preferred stock             227                  
Purchase additional shares         150,000                      
Public offering price per shares (in Dollars per share)         $ 5     $ 10                
Aggregate net proceeds (in Dollars)                     $ 4,940,948        
Issued warrants to purchase an aggregate amount     57,500                          
Exercise price (in Dollars per share)     $ 6.25                          
Restricted common shares           20,000                    
Restricted common value (in Dollars)           $ 135,100                    
Restricted common share price (in Dollars per share)           $ 6.755                    
Stock-based professional fees (in Dollars)                     1,726,061 1,496,687        
Repurchase of shares (in Dollars)                 $ 1,000,000   $ 471,121          
Stock repurchase program (in Dollars)                         $ 1,000,000      
Common stock purchase                     252,855          
Common stock purchase cost (in Dollars)                     $ 471,121          
Deferred compensation (in Dollars)                     $ 14,125 $ 111,014        
Stock options vest               16,000                
Fair value of unvested stock option 5,000 5,000                 6,000          
Common Stock [Member]                                
Stockholders’ Equity [Line Items]                                
Convertible common stock                       (15,167)        
Purchase additional shares         1,000,000                      
Aggregate net proceeds (in Dollars)     $ 4,940,948                          
Stock-based professional fees (in Dollars)                     $ 90,067 $ 45,033        
Repurchase of shares (in Dollars)                              
Minimum [Member]                                
Stockholders’ Equity [Line Items]                                
Common stock, shares authorized                           500,000,000    
Maximum [Member]                                
Stockholders’ Equity [Line Items]                                
Common stock, shares authorized                           100,000,000    
Warrant [Member]                                
Stockholders’ Equity [Line Items]                                
Exercise price (in Dollars per share)         $ 6.25                      
Purchase aggregate         57,500                      
Over-Allotment Option [Member]                                
Stockholders’ Equity [Line Items]                                
Purchase additional shares       150,000                        
Common Stock [Member]                                
Stockholders’ Equity [Line Items]                                
Shares authorized                     100,000,000          
Preferred Stock [Member]                                
Stockholders’ Equity [Line Items]                                
Shares authorized                     5,000,000          
Series C Convertible Preferred Stock [Member]                                
Stockholders’ Equity [Line Items]                                
Designated shares                             4,280  
Preferred stock, par value (in Dollars per share)                     $ 0.0001          
Stated value (in Dollars)                     $ 1,000          
Convertible preferred stock, description                     share of Series C Convertible preferred stock was convertible, at any time and from time to time after the issuance date, at the option of the holder, into such number of shares of common stock determined by dividing the Series C Stated Value by the Series C Conversion Price.          
Series C Conversion Price [Member]                                
Stockholders’ Equity [Line Items]                                
Conversion price per share (in Dollars per share)                     $ 15          
Series A Preferred Stock [Member]                                
Stockholders’ Equity [Line Items]                                
Share issued                              
Preferred Class B [Member]                                
Stockholders’ Equity [Line Items]                                
Shares outstanding                              
Conversion of Series C Convertible Preferred Stock into Common Stock [Member]                                
Stockholders’ Equity [Line Items]                                
Series C convertible preferred stock             227                  
Series C Preferred Stock [Member]                                
Stockholders’ Equity [Line Items]                                
Series C convertible preferred stock             227                  
Convertible common stock             15,167                  
Board Granted [Member]                                
Stockholders’ Equity [Line Items]                                
Public offering price per shares (in Dollars per share)                   $ 7.3            
Aggregate of incentive stock options                   6,849            
Stock option value (in Dollars)                   $ 30,224            
Risk free interest rate                   0.75%            
Expected dividend yield                   0.00%            
Expected term                   2 years            
Expected volatility                   115.00%            
Deferred compensation (in Dollars)                   $ 30,224            
Issuance of deferred compensation balance (in Dollars)                       $ 14,125        
Board Granted [Member] | Minimum [Member]                                
Stockholders’ Equity [Line Items]                                
Common stock issued under the plan                     300,000          
Board Granted [Member] | Maximum [Member]                                
Stockholders’ Equity [Line Items]                                
Common stock issued under the plan                     470,000          
Amendment [Member] | Minimum [Member]                                
Stockholders’ Equity [Line Items]                                
Common stock, shares authorized                           500,000,000    
Amendment [Member] | Maximum [Member]                                
Stockholders’ Equity [Line Items]                                
Common stock, shares authorized                           100,000,000    
Omnibus Equity Incentive Plan [Member]                                
Stockholders’ Equity [Line Items]                                
of common stock reserved and avail for issuance                               170,000
Incentive Stock Option [Member]                                
Stockholders’ Equity [Line Items]                                
Risk free interest rate                     1.18%          
Expected dividend yield                     0.00%          
Expected term                     2 years          
Expected volatility                     117.00%          
Fair value of unvested stock option                     16,000          
Fair value of stock option (in Dollars)                     $ 94,915          
Fair value of the unvested stock options (in Dollars)                     $ 94,915